loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Insecticides India Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Insecticides (India) Ltd. 11 Aug 2026 16:42 PM

Q1FY27 Quarterly Result Announced for Insecticides (India) Ltd.

Agrochemicals company Insecticides (India) announced Q1FY27 results

Consolidated Financial Highlights:

  • The company reported Revenue from Operations of Rs 61,152.31 lakh in Q1FY27, representing a YoY decrease of 11.52% from Rs 69,113.31 lakh in Q1FY26 and a QoQ increase of 43.46% from Rs 42,625.96 lakh in Q4FY26.
  • Total Income for Q1FY27 stood at Rs 61,686.70 lakh, compared to Rs 69,483.88 lakh in Q1FY26 (down 11.22% YoY) and Rs 43,099.15 lakh in Q4FY26 (up 43.13% QoQ).
  • Other Income for Q1FY27 was Rs 534.39 lakh, as against Rs 370.57 lakh in Q1FY26 and Rs 473.19 lakh in Q4FY26.
  • Profit Before Tax (PBT) reached Rs 5,882.05 lakh in Q1FY27, a YoY decrease of 24.06% from Rs 7,745.35 lakh and a QoQ increase of 266.12% from Rs 1,606.61 lakh.
  • Net Profit for the period (Profit for the period) was Rs 4,387.44 lakh in Q1FY27, marking a YoY decline of 24.49% from Rs 5,810.54 lakh and a QoQ growth of 274.68% from Rs 1,170.99 lakh in Q4FY26.
  • Total Comprehensive Income for Q1FY27 was Rs 4,227.61 lakh, compared to Rs 5,805.08 lakh in Q1FY26 and Rs 1,411.26 lakh in Q4FY26.
  • Basic and Diluted Earnings Per Share (EPS) for Q1FY27 stood at Rs 15.08, compared to Rs 19.97 in Q1FY26 and Rs 4.02 in Q4FY26.

Standalone Financial Highlights:

  • Revenue from Operations for Q1FY27 was Rs 61,648.22 lakh, reflecting a YoY decrease of 10.83% from Rs 69,137.24 lakh and a QoQ increase of 44.05% from Rs 42,795.60 lakh.
  • Total Income for the standalone entity reached Rs 62,110.58 lakh in Q1FY27, as against Rs 69,511.75 lakh in Q1FY26 and Rs 43,275.89 lakh in Q4FY26.
  • Standalone Profit Before Tax for Q1FY27 was Rs 5,626.47 lakh, compared to Rs 7,684.83 lakh in Q1FY26 (down 26.78% YoY) and Rs 1,870.24 lakh in Q4FY26 (up 200.84% QoQ).
  • Standalone Net Profit for Q1FY27 stood at Rs 4,183.05 lakh, showing a YoY decline of 27.00% from Rs 5,730.05 lakh and a QoQ increase of 191.22% from Rs 1,436.37 lakh.
  • Standalone Basic and Diluted EPS for Q1FY27 was Rs 14.38, compared to Rs 19.69 in Q1FY26 and Rs 4.94 in Q4FY26.

Business Highlights:

  • Subsidiary Update: The Board of Directors, in its meeting held on August 09, 2024, approved the dissolution/liquidation of its wholly owned subsidiary, IIL Overseas DMCC, Dubai. The dissolution was approved by the Registrar of Companies of Dubai Multi Commodities Centre Authority (DMCCA) vide its letter dated September 19, 2025.
  • Audit Review: The figures for the quarter ended March 31, 2026, are the balancing figures between audited figures for the full financial year ended March 31, 2026, and the unaudited published year-to-date figures up to December 31, 2025.

Rajesh Kumar Aggarwal, MD, Insecticides (India), said: We delivered a resilient performance during the quarter despite a subdued demand, supported by our diversified product portfolio, presence across key crops, strong execution capabilities, and clear strategic direction. While deficient rainfall impacted near-term revenue, pricing discipline and operating efficiencies helped maintain stability in gross margin. With an improving macro environment and focused execution, we remain confident of progressively building momentum through the coming quarters.

Our confidence is supported by the benefits emerging from sustained investments in premiumization, manufacturing, research, digital transformation, and global partnerships. The continued expansion of our Focus Maharatna and Maharatna portfolios, supported by collaborations with leading global innovators, is strengthening margins, deepening farmer engagement, enhancing the overall quality of growth. Additionally, Kaeros Research is evolving into a significant growth platform and the Company is advancing its international business footprint.

Supported by capacity expansion, backward integration, and operational excellence, we are building a more resilient and future-ready organization. We remain committed to delivering sustainable, high-quality growth and creating enduring value for farmers, partners, employees, and shareholders.

Result PDF

Agrochemicals company Insecticides (India) announced Q4FY26 & FY26 results

Consolidated Financial Highlights:

  • Revenue from Operations: Consolidated revenue for Q4FY26 was Rs. 42,625.96 lakh, a QoQ increase of 10.74% from Rs. 38,491.62 lakh and a YoY increase of 18.76% from Rs. 35,892.05 lakh. For the full year FY26, consolidated revenue reached Rs. 2,14,000.98 lakh compared to Rs. 1,99,994.96 lakh in FY25.
  • Total Income: Consolidated total income for FY26 stood at Rs. 2,15,171.86 lakh compared to Rs. 2,00,694.51 lakh in FY25.
  • Profit Before Tax (PBT): For the full year FY26, consolidated PBT was Rs. 18,667.93 lakh compared to Rs. 19,276.99 lakh in FY25.
  • Net Profit: Consolidated net profit for FY26 was Rs. 13,941.10 lakh, compared to Rs. 14,201.86 lakh in FY25.
  • Total Comprehensive Income: For the full year FY26, consolidated total comprehensive income was Rs. 14,163.75 lakh compared to Rs. 14,067.69 lakh in FY25.

Standalone Financial Highlights:

  • Revenue from Operations: For Q4FY26, the company reported revenue of Rs. 42,795.60 lakh, representing a QoQ increase of 11.57% compared to Rs. 38,356.38 lakh in Q3FY26 and a YoY increase of 19.16% compared to Rs. 35,914.51 lakh in Q4FY25. For the full year FY26, revenue stood at Rs. 2,14,414.11 lakh compared to Rs. 2,00,226.58 lakh in FY25, a growth of 7.09%.
  • Total Income: Total income for Q4FY26 was Rs. 43,275.89 lakh, up 12.56% QoQ from Rs. 38,445.26 lakh and up 19.52% YoY from Rs. 36,208.05 lakh. For the full year FY26, total income reached Rs. 2,15,625.23 lakh against Rs. 2,00,949.16 lakh in FY25.
  • Profit Before Tax (PBT): The PBT for Q4FY26 stood at Rs. 1,870.24 lakh, showing a QoQ growth of 52.87% over Rs. 1,223.41 lakh in Q3FY26, but a YoY decline of 15.95% compared to Rs. 2,225.13 lakh in Q4FY25. For FY26, PBT was Rs. 18,197.70 lakh compared to Rs. 19,028.49 lakh in FY25.
  • Net Profit: Net profit for Q4FY26 was Rs. 1,436.37 lakh, a QoQ increase of 62.43% from Rs. 884.30 lakh and a YoY increase of 2.42% from Rs. 1,402.49 lakh. For the full year FY26, net profit was Rs. 13,581.74 lakh compared to Rs. 13,976.56 lakh in FY25.
  • Total Comprehensive Income: For the full year FY26, total comprehensive income was Rs. 13,803.30 lakh compared to Rs. 13,848.59 lakh in FY25.

Business Highlights:

  • Segment Performance: The company operates in a single business segment, "Agro-Chemicals," which comprises Technical and Formulation activities.
  • New Employee Stock Purchase Scheme: The Board approved the "IIL ESPS Scheme 2026," covering an aggregate number of up to 2,00,000 equity shares of face value Rs. 10 each. The scheme is subject to shareholder approval at the upcoming 29th Annual General Meeting.
  • Board and Management Changes:
    • The Board accepted the resignation of Mrs. Nikunj Aggarwal as Whole Time Director with effect from May 28, 2026.
    • Mr. Sanskar Aggarwal was appointed as Whole Time Director (Additional) for a five-year term effective from May 28, 2026, to May 27, 2031.
    • Mr. Atul Kumar was appointed as Vice President - Sales (North).
  • Subsidiary Liquidation: The company completed the dissolution/liquidation of its wholly owned subsidiary, IIL Overseas DMCC, Dubai, which was approved by the registrar on September 19, 2025.
  • Internal Auditor Appointment: M/s. T Jain & Associates, Chartered Accountants, were appointed as Internal Auditors for a five-year period from April 01, 2026, to March 31, 2031.
  • Annual General Meeting: The 29th AGM is scheduled to be held on Wednesday, August 12, 2026.

Commenting on the results and performance, Rajesh Kumar Aggarwal, MD of Insecticides (India). said: “Insecticides (India) Limited delivered a steady performance during the year, supported by healthy growth momentum and stable margins, despite a challenging operating environment marked by erratic rainfall, restricted field activities, and global disruptions.

The Company continued to strengthen its innovation-led product portfolio through successful launches in collaboration with leading global partners. Key launches included Altair with Nissan Chemical Corporation and Sparcle & Granuvia with Corteva Agriscience, offering reliable, easy-to-use, and next-generation crop solutions to Indian farmers.

To further enhance market reach and distribution depth, we introduced B2C products under Kaeros Research Limited, wholly owned subsidiary of the Company. Going forward, IIL remains focused on strengthening its product pipeline, expanding strategic collaborations, enhancing organizational capabilities, premiumizing its brand equity, deepening dealer and farmer engagement, and driving innovative marketing initiatives/

Amid global uncertainties, the Company remains agile and committed to building a stronger, more resilient, and future-ready organization.

Result PDF

Agrochemicals company Insecticides (India) announced Q3FY26 results

  • Revenue: Rs 38,491.62 crore against Rs 35,770.47 crore during Q3FY25, change 8%.
  • PBT: Rs 1,430.26 crore against Rs 2,228.16 crore during Q3FY25, change -36%.
  • PAT: Rs 1,048.82 crore against Rs 1,736.5 crore during Q3FY25, change -40%.
  • EPS: 3.6 for Q3FY26.

Result PDF

Agrochemicals company Insecticides (India) announced Q2FY26 results

  • Revenue from Operations: Rs 637.70 crore against Rs 626.64 crore during Q2FY25, change 2%.
  • EBITDA: Rs 89.48 crore against Rs 89.72 crore during Q2FY25.
  • EBITDA Margin: 14.03% for Q2FY26.
  • PAT: Rs 59.11 crore against Rs 61.39 crore during Q2FY25, change -4%.

Rajesh Kumar Aggarwal, MD, Insecticides (India) Ltd, said: “Insecticides (India) has delivered a resilient performance in Q2 with sales growth of 2% and sustained profitability, despite challenging weather conditions. The Company proactively expanded sales and distribution efforts to stay closer to farmers, complemented by several new product introductions during H1. Persistent and wide spread rains since mid-July, led to significant crop damage across regions and limited farmers’ access to fields. Consequently, agrochemical consumption remain subdued, accompanied by higher working capital utilization. Our continued focus on innovation, premiumization, and Complete Crop Solutions has helped strengthen our brand saliency and reinforced our market presence.

Our collaboration with Corteva Agriscience is a strong step towards bringing global innovations to Indian farmlands. By combining Corteva Agriscience’s advanced technology with Insecticides (India) extensive market reach, we aim to deepen our engagement with farmers through a strong portfolio of premium products. We are also pleased to welcome Mr. Devendra Kumar Ray as Chief Operating Officer of the Company. An industry veteran with over thirty five years of experience in large scale chemical manufacturing and operations management. We continue to remain focused on enhancing operational efficiency and strengthening our organisational capabilities.

Both domestic and global market conditions indicate a cohesive growth environment for the industry, underpinned by firmness in raw material prices across key product categories. Looking ahead, we remain optimistic, supported by adequate soil moisture, favourable Rabi sowing prospects, and stable input pricing. With a strong product pipeline, upcoming launches, and deeper farmer engagement, we are well-positioned to drive revenue growth and sustain profit margins. Our commitment to innovation, sustainability, and value creation remains unwavering as we continue to empower India’s farmers and strengthen our leadership in the crop protection and nutrition space."

Result PDF

Agrochemicals company Insecticides (India) announced Q1FY26 results

  • Revenue from Operations: Rs 691.13 crore compared to Rs 656.69 crore during Q1FY25, change 5%.
  • EBITDA: Rs 84.59 crore compared to Rs 72.13 crore during Q1FY25, change 17%.
  • EBITDA Margin: 12.2% for Q1FY26.
  • PAT: Rs 58.11 crore compared to Rs 49.37 crore during Q1FY25, change 18%.

Rajesh Kumar Aggarwal, MD of Insecticides (India), said: “We are pleased to report a strong start to this season, with diverse offerings of premium products, three new product launches and effective marketing initiatives. Our continued emphasis on premiumization delivered encouraging results, leading to an improvement in profitability wherein PAT grew by 18% in Q1FY26. This performance reflects the effectiveness of our strategic framework, which emphasises sustained margin improvement, a sharper focus on premium products, and a complete crop solution provider.

The business environment remained broadly favourable during the quarter. The season commenced with an early onset of the Southwest monsoon, healthy reservoir levels and visible signs of global demand recovery with stable raw material prices. Kharif season started well for certain crops like Rice, Maize, while uneven rain in certain parts impacted the sowing of other crops.

We are now considered an innovative crop solution provider, wherein we are seen by the farmers as their reliable partner, engaging early from sowing till harvest. And will provide a leadership position in major crops in India. Another transformative step was IIL Crop Solution Plots. These are model fields cultivated using IIL Crop Solutions for major crops, helping farmers and channel partners to experience the benefits in terms of differences in crop health, yield, and overall productivity.

During the quarter, we launched three new products, including Altair a patented pre-emergent herbicide for paddy developed by Nissan Chemical Corporation, Japan—which will be exclusively marketed by us in India. With overwhelming response to the new launches of the last few years, we are well-positioned to capitalise on emerging opportunities. Our Dahej facility has received the necessary approvals and will contribute significantly to our growth requirements and efficient operational management.

Looking ahead, we remain optimistic about the season, supported by favourable tailwinds such as a strong monsoon, rising reservoir levels, and expanded crop sowing. Our growth outlook remains strong for premium products, driven by deeper farmer connections and continued expansion of our product portfolio. We are deeply committed to sustainability, innovation, and responsible growth with continued focus on delivering long-term value to our stakeholders while making a positive impact on the environment and the communities we serve. With a strong foundation and a clear strategic vision, we are confident in building a resilient and promising future for our business.”

Result PDF

Agrochemicals company Insecticides (India) announced Q4FY25 & FY25 results

Q4FY25 Financial Highlights:

  • Revenue from Operations: Rs 358.92 crore in Q4FY25, showing a 32% growth compared to Rs 272.50 crore in Q4FY24.
  • Gross Profit: Rs 131.36 crore in Q4FY25, showing a 51% growth compared to Rs 86.84 crore in Q4FY24.
  • EBITDA: Rs 28.47 crore in Q4FY25, showing a 226% growth compared to Rs 8.73 crore in Q4FY24.
  • EBITDA Margin (%): 7.9% in Q4FY25, compared to 3.2% in Q4FY24.
  • Profit After Tax: Rs 13.89 crore in Q4FY25, showing an 85% growth compared to Rs 7.52 crore in Q4FY24.

FY25 Financial Highlights:

  • Revenue from Operations: Rs 1,999.95 crore in FY25, showing a 2% growth compared to Rs 1,966.39 crore in FY24.
  • Gross Profit: Rs 640.83 crore in FY25, showing a 28% growth compared to Rs 501.36 crore in FY24.
  • EBITDA: Rs 221.22 crore in FY25, showing a 36% growth compared to Rs 162.32 crore in FY24.
  • EBITDA Margin (%): 11.1% in FY25, compared to 8.3% in FY24.
  • Profit After Tax: Rs 142.02 crore in FY25, showing a 39% growth compared to Rs 102.07 crore in FY24.

Commenting on the results and performance, Rajesh Kumar Aggarwal, MD of Insecticides (India) said: “We are pleased to report a robust performance of the Company, marked by strong execution and strategic discipline, resulting in a profit growth of 39% in FY25. This performance underscores the success of the strategic framework we established —centered around profitable growth, a sharper focus on premium products, and margin enhancement. The overall business environment remained favorable throughout the year. A good monsoon and healthy reservoir levels provided strong tailwinds for rural demand and agri-input consumption. Additionally, stable raw material prices and our deep farmer connect further supported steady demand across markets.

Our continued focus on premiumization yielded positive results, driving an improvement in gross margins. We consciously prioritized value over volume, reflecting our long-term strategy of sustainable, profitable growth. This disciplined approach also led to an improvement in key return metrics, with both ROCE and ROE improving consistently even in FY25, a direct outcome of better product mix and efficient capital allocation.

Looking ahead, we remain optimistic about the upcoming seasons. We expect continued momentum supported by favorable macro tailwinds such as a strong monsoon forecast and stable raw material prices. Our growth outlook remains intact, with expectations of expansion in premium products, stable gross profit margins, and EBITDA improvement, driven by new launches and operational efficiencies.

Recently we also launched Altair, a patented pre-emergent herbicide for paddy developed by Nissan Chemical Corporation, Japan, which will be exclusively marketed by us in India. This launch is a testament of our commitment to deliver innovative and effective solutions that address the real challenges faced by Indian farmers. With a robust product pipeline and planned launches in the coming year and in recent years, we are well-positioned to capture emerging opportunities in the market. While continued investment in future majorly at Dahej capacity expansion and upgraded technical and formulation facilities at Sotanala, Rajasthan.

We remain deeply committed to sustainability, innovation, and responsible growth. As we move forward, our focus stays firmly on delivering long-term value for our stakeholders, while creating a positive impact on the environment and the communities we serve. With a strong foundation and clear vision, we are confident in building a resilient, promising future for our business.”

Result PDF

Agrochemicals company Insecticides (India) announced Q3FY25 results

Financial Highlights:

  • Revenue from Operations for Q3FY25 remained stable at Rs 357.7 crore, similar to Rs 357.9 crore in Q3FY24.
  • Gross Profit increased by 20% YoY to Rs 129.2 crore from Rs 108.0 crore, with Gross Profit Margin improving to 36.1% (vs. 30.2%).
  • EBITDA grew by 19% YoY to Rs 30.9 crore from Rs 26.0 crore, with EBITDA Margin expanding to 8.6% from 7.3%.
  • PAT saw a 42% YoY increase, reaching Rs 17.4 crore compared to Rs 12.3 crore in Q3FY24.

Business Highlights:

  • Robust growth in recent launches like Mission, Mission SC, Shinwa, Izuki in first nine months. B2B sales remain impacted with challenging macro market conditions.
  • 10 new products launched in first nine months including patented latest technology products
  • Launched Centran, a patented 9(3) insecticide with dual-action for paddy. It aims to boost productivity and support farmers' economic growth
  • Torry Super an innovative 9(3) herbicide for maize which is based on SPF technology, developed by in-house R&D team
  • Tie up with BioPrime to brings Relieve, it is exclusive biological product for the Indian market, furthering efforts to provide sustainable solutions for Indian agriculture.
  • Received Patent for IZUKI, a fungicide for paddy. This has been developed in technical collaboration with Nissan Chemical Corporation Japan

Rajesh Aggarwal, MD of Insecticides (India) said: “We are excited to share our robust performance during current quarter with 42% growth in PAT. This is in line with the strategic framework established at start of the year focusing on profitable growth with higher share of Premium Products and improving its margins. The first nine months has been in line with expectations, driven by strong contributions from our premium product range, which now constitutes 62% of B2C revenue and significant improvements in our EBITDA margins.

We are optimistic about the upcoming seasons, supported by favorable tailwinds such as a strong monsoon, increased reservoir levels, and enhanced crop sowing. Furthermore, government policies in latest Union Budget for increasing farmer income and thrust on increasing output for cotton, pulses etc. are expected to provide additional positive momentum. We are delighted to share that we have received an overwhelming response from market to our new launches providing latest technology and complete crop solution to the farmers. Our commitment to innovation remains steadfast as we continue to enhance our technology offerings for farmers.

In Q2 FY25, we acquired Kaeros Research Private Limited aimed at securing supply chains and reducing costs through direct imports. Kaeros holds import licenses and vendor approvals, providing valuable benefits. The acquisition was executed at fair value and is accretive to shareholder value. The Company’s fully paid-up capital is Rs. 4.78 crores, with land assets situated in Shamli, Uttar Pradesh used for field trials.

We remain committed to investing in cutting-edge technology, fostering innovation, and ensuring operational excellence to deliver sustainable, profitable growth. With a clear vision and a solid foundation, we are confident in our ability to generate lasting value for our stakeholders and build a promising future for our business.”

Result PDF

Agrochemicals company Insecticides (India) announced Q2FY25 results

  • Revenue from Operations: Rs 627 crore compared to Rs 696 crore during Q2FY24, change -10%.
  • EBITDA: Rs 90 crore compared to Rs 82 crore during Q2FY24, change 9%.
  • EBITDA margin: 14.3% for Q2FY25.
  • PAT: Rs 61 crore compared to Rs 53 crore during Q2FY24, change 16%.
  • PAT margin: 9.8% for Q2FY25.

Rajesh Aggarwal, MD of Insecticides (India), said: “We are pleased to announce our Q2 & H1FY25 results, reflecting healthy performance across key financial and operational metrics. Achieving Net Profit of Rs 111 crore in first half, we have already surpassed the full FY24 profit of Rs 102 crore—a testament to the strength of our strategy and execution. Our focus will remain on driving higher growth in premium products, underpinned by New Product Launches, more extensive demand generation and brand-building initiatives.

During the quarter, we observed firming up of raw material prices although excessive and continued rainfall resulted in lower pest infestation. The farmers delayed their spraying schedule, which adversely impacted revenue growth for the Company. The monsoon has been marking India’s wettest monsoon in four years, with rainfall exceeding 100% of the long term average, resulting an increase in sowing for Kharif crop and promising outlook for Rabi season

This quarter, we have launched an innovative 9(3) herbicide for maize, Torry Super based on SPF technology, developed by in-house R&D team. SPF technology of Torry Super will provide faster results and long duration control of weeds. We are getting an overwhelming response of Torry Super in maize of Rabi season in the southern & western part of the country, where season has already begun. Our strategic emphasis remains on premiumisation, capital efficiency and surplus cash generation with visible improvement across profitability, working capital & ROCE, ROE.

In a move to reward our shareholders, we completed a buyback of 500,000 fully paid-up equity shares at Rs 1,000 each, amounting to Rs 50 crore, through internal accrual.

With favorable market conditions and intense focus on premiumisation, we expect healthy profit growth and leaner balance sheet as we progress into this financial year.“

Result PDF

Agrochemicals company Insecticides (India) announced Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Revenue from Operations stood at Rs 273 crore in Q4FY24 compared to Rs 302 crore in Q4FY23
  • EBITDA stood at Rs 9 crore in Q4FY24 as against Rs (28) crore in Q4FY23
  • PAT stood at Rs 8 crore in Q4FY24 as against a loss of Rs (29) crore in Q4FY23

FY24 Financial Highlights:

  • Net Revenues for FY24 stood at Rs 1,966 crore vs Rs 1,801 crore in FY23
  • B2C business revenue grew by 11% leading to higher profitability
  • Strong growth of 27% in value added product portfolio of ‘Maharatna’, which constitutes 59% of B2C revenue in FY24
  • B2B and Exports revenue remains impacted due to industry challenges
  • Favorable product mix and costs efficiencies led improvement in profitability
  • PAT for FY24 was at Rs 102 crore, registering a growth of 62%; PAT margins expand by 170 bps in FY24 marking a strong recovery in a challenging industry environment

Commenting on the results and performance, Rajesh Aggarwal, MD of Insecticides (India) Ltd. said: “We are delighted to report a strong performance for Q4FY24 and FY24, with our annual net profit crossing Rs 100 crore, representing a 62% year-over-year growth compared to FY23. This achievement is a testament to our resilience and adaptability in a challenging industry environment.

Our revenue for FY24 stood at Rs 1,966 crore, registering a 9% growth, primarily driven by the impressive performance of our focused Maharatna and Maharatna products, which saw a remarkable 27% year-over-year growth and contributed 59% to our total sales. We attribute this success to our strategic focus on product mix optimization and cost efficiencies, which led to improved profitability and higher GP and EBITDA margins.

Our commitment to operational excellence has enabled us to optimize costs, improve efficiency, and remain agile in response to changing market conditions. We continue to invest in our premium product portfolio, distribution network, and brand equity, reinforcing our position as a trusted partner for farmers and agricultural stakeholders.

We have introduced 8 new products in FY24, which generated revenue of Rs 51 crore and demonstrated wider product acceptance, driving innovation and value. Looking ahead, we are excited about the prospects for our new product launches, which will further enhance our portfolio and address the needs of the farmers. This will lead us to be close to the farmers and address the emerging needs of the farmers on an ongoing basis. We expect to launch at least 7-8 new products in FY25.

Our dedication to sustainability and responsible growth remains unwavering, as we strive to make a positive impact on the environment and the communities we serve. We are grateful for the support of our stakeholders, whose trust and confidence in our vision have been instrumental in our success. As we move forward, we remain committed to innovation, sustainability, and excellence, driving growth and value for all our stakeholders."

Result PDF

Agrochemicals company Insecticides (India) announced Q1FY24 results:

  • Revenue from operations increased by 14.14% to Rs 6,399.53 million in Q1FY24 from Rs 5,606.90 million in Q1FY23 on account of favourable monsoon conditions and increasing share of Focused Maharatna products like Hachiman, Shinwa and Torry as a result of our step ahead go-to-market strategies.
  • EBITDA margins stood at 7.13% in Q1FY24, a decrease of 329 bps on account of the liquidation of high-cost inventory from the previous year. The high-cost inventory is significantly liquidated from the balance sheet.
  • PAT stood at Rs 291.42 million in Q1FY24, compared to Rs 383.09 million in Q1FY23, margins reduced from 6.83% in Q1FY23 to 4.55% in Q1FY24.

Commenting on the performance the management team of Insecticides (India) stated, “We had a strong quarter to start the year in terms of revenue growth as we witnessed a robust demand for our products owing to favourable monsoon. Although there was an initial delay in rains in certain regions of the country, our widespread presence across India mitigated the impact of this factor and helped us achieve a growth of 14.14% YoY in Revenue from Operations. However, the spillover impact of high-cost inventory from the previous year and pricing pressure impacted EBITDA & PAT Margins which stood at 7.13% and 4.55% respectively for Q1FY24.

We took proactive measures to address the challenges by optimizing our inventory management, ensuring that we maintain a healthy stock level while minimizing the accumulation of high-cost inventory. Furthermore, we are closely monitoring weather patterns and market dynamics to anticipate any potential disruptions to our business operations. By staying agile and responsive, we aim to minimize the impact of external factors on our performance and maintain a sustainable growth trajectory

Looking ahead, we anticipate a sustainable growth trajectory in the market driven by favourable monsoon conditions, an array of Maharatna product launches and stabilisation of prices.

We recently launched promising products in the form of Mission granule and Mission liquid, both of which have received very positive responses from the market and contributed to our topline. Products launched in the last few years like Torry, Hachiman, Shinwa, Green Label, Izuki, Dominant and Kunoichi have started yielding positive results, gaining massive tractions as a result of our concentrated marketing efforts on the entire Focused Maharatna range. We are at a turnaround point where micro-go-to-market strategies have played a vital role to spread brand awareness at the ground level to educate the farmers. Additionally, we are expecting to launch three herbicide Maharatna combination products under 9(3) and one insecticide Maharatna product under 9(4) in Q2 and Q3 usage will be across multiple crops.

Export markets were impacted in FY23 and Q1FY24 by the EL Nino impact in major export markets like North America, Europe, LatAm, and Africa which led to lower demand for agro-inputs and consequently to lower prices. In addition to the above, currency fluctuations and precarious levels of forex reserves with several importing countries led to a delay in the recovery of dues for the entire industry which prompted us to deploy a calibrated approach for exports. However, we have now started witnessing positive signs from the export market such as receiving multiple orders from the dealers, stabilization and upward movement in prices of raw material.

Further, to stay relevant and expand our international footprints, we are actively seeking more than 300 registrations in Europe, Latin America and USA markets. We expect to further increase our registrations in upcoming years.

At IIL, we continue to move forward on our mission to grow responsibly towards a sustainable future through continuous support of our employees and other stakeholders I would like to conclude by thanking all our stakeholders for helping us move in the right direction.”

 

 

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Get it on google Play Store Download on the App Store
market app